









Markets
/
Stocks
/
nasdaq-lfst
/

Lifestance Health Group Inc

LFST

6.320USD

-0.370-5.53%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

2.36BMarket Cap

252.50P/E TTM



Lifestance Health Group Inc

6.320

-0.370-5.53%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Lifestance Health Group Inc

Currency: USD Updated: 2026-03-27

Key Insights

Lifestance Health Group Inc's fundamentals are relatively very healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 8 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.72.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Lifestance Health Group Inc's Score

Industry at a Glance

Industry Ranking

8 / 75

Overall Ranking

75 / 4542

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Lifestance Health Group Inc Highlights

StrengthsRisks

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 34.92% year-on-year.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Overvalued

The company’s latest PE is 252.50, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 367.92M shares, decreasing 3.17% quarter-over-quarter.

Held by Joel Greenblatt

Star Investor Joel Greenblatt holds 74.84K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.93.

Analyst Rating

Based on 11 analysts

Buy

Current Rating

9.722

Target Price

+50.73%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Lifestance Health Group Inc is 8.37, ranking 13 out of 75 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 382.19M, representing a year-over-year increase of 17.43%, while its net profit experienced a year-over-year increase of 264.06%.

Score

Industry at a Glance

Previous score

8.37

Change



Financials

8.74

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.88

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.97

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.27

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Lifestance Health Group Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Lifestance Health Group Inc is 8.61, ranking 6 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 252.50, which is 17.25% below the recent high of 296.04 and 224.09% above the recent low of -313.31.

Score

Industry at a Glance

Previous score

8.61

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 8/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Lifestance Health Group Inc is 8.18, ranking 24 out of 75 in the Healthcare Providers & Services industry. The average price target is 8.25, with a high of 10.00 and a low of 6.50.

Score

Industry at a Glance

Previous score

8.18

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 11 analysts

Buy

Current Rating

9.722

Target Price

+50.73%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Lifestance Health Group Inc

LFST

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Lifestance Health Group Inc is 6.61, ranking 40 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 7.09 and the support level at 5.88, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.17

Change

-0.56

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.000

Sell

RSI(14)

39.276

Neutral

STOCH(KDJ)(9,3,3)

46.480

Sell

ATR(14)

0.226

Low Volatility

CCI(14)

-52.479

Neutral

Williams %R

85.065

Oversold

TRIX(12,20)

-0.379

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

6.528

Sell

MA10

6.494

Sell

MA20

6.675

Sell

MA50

6.930

Sell

MA100

6.783

Sell

MA200

5.891

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Lifestance Health Group Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 94.58%, representing a quarter-over-quarter increase of 1.75%. The largest institutional shareholder is The Vanguard, holding a total of 17.65M shares, representing 4.53% of shares outstanding, with 57.39% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

TPG Capital, L.P.

160.71M

Fidelity Management & Research Company LLC

32.90M

+42.51%

Summit Partners, L.P.

33.52M

The Vanguard Group, Inc.

Star Investors

14.58M

+19.54%

Silversmith Capital Partners

14.32M

-20.05%

BlackRock Institutional Trust Company, N.A.

11.99M

+24.09%

Dimensional Fund Advisors, L.P.

8.36M

+27.24%

Jennison Associates LLC

7.43M

+2.31%

Geode Capital Management, L.L.C.

3.96M

+17.73%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Lifestance Health Group Inc is 5.99, ranking 35 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.11. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Lifestance Health Group Inc’s latest ESG disclosure is at an average level in the Healthcare Providers & Services industry, showing no material impact on overall risk.